Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.

Rosenau J, Kreutz T, Kujawa M, Bahr MJ, Rifai K, Hooman N, Finger A, Michel G, Nashan B, Kuse ER, Klempnauer J, Tillmann HL, Manns MP.

J Hepatol. 2007 Apr;46(4):635-44. Epub 2007 Jan 25.

PMID:
17316869
2.

Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?

van Nunen AB, de Man RA, Heijtink RA, Vossen AC, Schalm SW.

J Viral Hepat. 2002 May;9(3):221-8.

PMID:
12010511
3.

Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.

Hooman N, Rifai K, Hadem J, Vaske B, Philipp G, Priess A, Klempnauer J, Tillmann HL, Manns MP, Rosenau J.

Liver Transpl. 2008 Apr;14(4):435-42. doi: 10.1002/lt.21343.

4.

Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.

Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, Li F, Zhou Y, Zhang L.

Vaccine. 2014 Oct 21;32(46):6091-7. doi: 10.1016/j.vaccine.2014.08.078. Epub 2014 Sep 18.

PMID:
25240752
5.

Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.

Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL.

Hepatology. 1996 Dec;24(6):1327-33.

PMID:
8938155
6.

Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.

Tchervenkov JI, Tector AJ, Barkun JS, Sherker A, Forbes CD, Elias N, Cantarovich M, Cleland P, Metrakos P, Meakins JL.

Ann Surg. 1997 Sep;226(3):356-65; discussion 365-8.

7.

Effectiveness of low-dose intramuscular anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report.

Alonso I, Herreros de Tejada A, Moreno JM, Rubio E, Lucena JL, De la Revilla J, Sánchez Turrión V, Gomez A, Lopez J, Cuervas-Mons V.

Transplant Proc. 2003 Aug;35(5):1850-1.

PMID:
12962821
8.
9.

De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.

Ueda Y, Marusawa H, Egawa H, Okamoto S, Ogura Y, Oike F, Nishijima N, Takada Y, Uemoto S, Chiba T.

Antivir Ther. 2011;16(4):479-87. doi: 10.3851/IMP1771.

PMID:
21685535
10.
11.

Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study.

De Simone P, Romagnoli R, Tandoi F, Carrai P, Ercolani G, Peri E, Zamboni F, Mameli L, Di Benedetto F, Cillo U, De Carlis L, Lauterio A, Lupo L, Tisone G, Prieto M, Loinaz C, Mas A, Suddle A, Mutimer D, Roche B, Wartenberg-Demand A, Niemann G, Böhm H, Samuel D.

Transplantation. 2016 Jul;100(7):1507-12. doi: 10.1097/TP.0000000000001171.

12.

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.

Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, Lionetti R, Casciani CU, Tisone G.

Hepatology. 2002 Jan;35(1):176-81.

PMID:
11786974
13.

Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.

Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, McCaughan GW; Australasian Liver Transplant Study Group.

Gastroenterology. 2007 Mar;132(3):931-7. Epub 2007 Jan 5.

PMID:
17383422
14.

Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.

Karasu Z, Ozacar T, Akyildiz M, Demirbas T, Arikan C, Kobat A, Akarca U, Ersoz G, Gunsar F, Batur Y, Kilic M, Tokat Y.

Antivir Ther. 2004 Dec;9(6):921-7.

PMID:
15651751
15.

Retransplantation of patients with severe posttransplant hepatitis B in the first allograft.

Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, Terrault N, Roberts J, Ascher N, Wright T, Lake J.

Transplantation. 1997 Aug 15;64(3):410-4.

PMID:
9275104
16.

Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.

Rosenau J, Hooman N, Hadem J, Rifai K, Bahr MJ, Philipp G, Tillmann HL, Klempnauer J, Strassburg CP, Manns MP.

Liver Transpl. 2007 Mar;13(3):367-73.

17.

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

Sánchez-Fueyo A, Rimola A, Grande L, Costa J, Mas A, Navasa M, Cirera I, Sánchez-Tapias JM, Rodés J.

Hepatology. 2000 Feb;31(2):496-501.

PMID:
10655276
18.

HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis.

Roche B, Feray C, Gigou M, Roque-Afonso AM, Arulnaden JL, Delvart V, Dussaix E, Guettier C, Bismuth H, Samuel D.

Hepatology. 2003 Jul;38(1):86-95.

PMID:
12829990
19.

Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.

Dickson RC, Terrault NA, Ishitani M, Reddy KR, Sheiner P, Luketic V, Soldevila-Pico C, Fried M, Jensen D, Brown RS Jr, Horwith G, Brundage R, Lok A.

Liver Transpl. 2006 Jan;12(1):124-33.

20.

Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization.

Müller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, Tusch G, Lautz HU, Böker K, Stangel W, et al.

J Hepatol. 1991 Jul;13(1):90-6.

PMID:
1918881

Supplemental Content

Support Center